lundi 18 avril 2022

Scientists Question Data Behind an Experimental Alzheimer’s Drug

Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.

from NYT > Health https://ift.tt/kwGinRK
via health&fitness

Aucun commentaire:

Enregistrer un commentaire